Follow-up analysis of the efficacy of photodynamic therapy in actinic keratosis

British Journal of Dermatology

Volumn 169, Issue 5, 2013, Pages 1156-

  Kolde, G ^a  

^a Dermatologic Center Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DRUG DERIVATIVE; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFICACY; ELDERLY CARE; FACE; FACE INJURY; FOLLOW UP; HUMAN; LETTER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; SCALP; SEX RATIO; SKIN DEFECT; SUN EXPOSURE; FEMALE; MALE; METHODOLOGY; NOTE; PHOTOCHEMOTHERAPY;

AMINOLEVULINIC ACID; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84887042911     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12558     Document Type: Letter

References (4)

1. Dirschka T, Radny P, Dominicus R, et al,. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol 2013; 168: 825-36.
2. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-9.
3. Naldi L, Chatenoud L, Piccitto R, et al,. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004. Arch Dermatol 2006; 142: 722-6.
4. Traianou A, Ulrich M, Apalla Z, et al,. Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol 2012; 167 (Suppl. 2): 36-42.